皇冠体育app

World headquarters of Pfizer Inc in New York. [Photo/皇冠体育app Daily]

-- 皇冠体育app's drug watchdog has decided to stop importing an injection from the Pfizer Inc., as the US pharmactical maker failed in a supplementary application for drug exports.

皇冠体育app will not import Pfizer's Fluconazole injection, used to treat monilial infection, until the company makes correction, the State and Drug Administration announced Tuesday.

The administration said it recently inspected Pfizer's Amboise factory in France and found that the factory did not submitted relevant supplementary applications in accordance with Chinese law and regulations.

The administration had invited staff from the company for a meeting, it said.

It urged overseas pharmaceutical companies to strictly abide by relevant Chinese laws and regulations on drugs and warned them not to adopt "differentiated treatment" policies in technological standards and drug quality.

Those who violate Chinese laws and regulations will be warned or banned from exporting drugs to or selling drugs in 皇冠体育app, according to the administration.X Regarding 皇冠体育app's import ban, Pfizer said in a statement on Tuesday that the problem does not involve safety and quality.

Pfizer respects and values 皇冠体育app's laws and regulations and has taken correction measures, it said, adding that it will continue to cooperate with 皇冠体育app's drug authorities to ensure all its overseas factories supplying the Chinese market meet 皇冠体育app's legal requirements.